Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients

Author： Tarnowski B.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.88, Iss.3, 2004-12, pp. : 287-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The aim of the study was to compare VEGF serum levels in breast cancer patients with and without BRCA1 gene mutation. We enrolled 80 patients, 22 premenopausal and 58 postmenopausal. We found statistically significant lower levels of VEGF in patients with BRCA1 gene mutation as compared with breast cancer patients without this mutation.

Related content

Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma

By Groves Morris   Hess Kenneth   Puduvalli Vinay   Colman Howard   Conrad Charles   Gilbert Mark   Weinberg Jeffrey   Cristofanilli Massimo   Yung W.   Liu Ta-Jen  

Journal of Neuro-Oncology, Vol. 94, Iss. 2, 2009-09 ,pp. : 229-234 (6)

Springer Publishing Company

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor (VEGF) Serum Levels Are Associated With Survival in Early Stages of Lung Cancer Patients

By Pau Enrique Carrillo-de Santa   Arias Fernando Carrillo   Pelaez Enrique Caso   Trueba Ignacio Muguruza   Hernández Ignacio Sánchez   Molina Gemma María Muñoz   Balsalobre Ramón Moreno   López Silvia Sacristán   Gómez-Pinillos Alejandro   Toledo Lobo Maria del Val  

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 393-398 (6)

Informa Healthcare

Access to resources Recommend Favorite

Serum Vascular Endothelial Growth Factor (VEGF) Levels Correlate with Tumor VEGF and p53 Overexpression in Endocrine Positive Primary Breast Cancer

By Iovino F.   Ferraraccio F.   Orditura M.   Antoniol G.   Morgillo F.   Cascone T.   Diadema M. R.   Aurilio G.   Santabarbara G.   Ruggiero R.   Belli C.   Irlandese E.   Fasano M.   Ciardiello F.   Procaccini E.   Schiavo F. Lo   Catalano G.   De Vita F.  

Cancer Investigation, Vol. 26, Iss. 3, 2008-02 ,pp. : 250-255 (6)

Informa Healthcare

Access to resources Recommend Favorite

Vascular endothelial growth factor polymorphisms affect gene expression and tumor aggressiveness in patients with breast cancer

By            

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 1044-1048 (5)

Spandidos Publications

Access to resources Recommend Favorite

High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1103-1108 (6)

Science Publishers

Access to resources Recommend Favorite